Anti-senescence effect and molecular mechanisms of royal jelly (RJ) and its components on cellular senescence, healthy aging, and longevity induced by endogenous and exogenous factors
Anti-senescence effect and molecular mechanisms of royal jelly (RJ) and its components on cellular senescence, healthy aging, and longevity induced by endogenous and exogenous factors. Cellular senescence is triggered by various intrinsic and extrinsic stimuli such as ROS, inflammation, mitochondrial dysfunction, genotoxic stress, irradiation and chemotherapeutic agents, telomere shortening, irreversible DNA damage, or signals such as oncogene activation or the overexpression of pluripotency factors. These stressors initiate various cellular signaling cascades, ultimately resulting in the activation of p53, p16Ink4a, or both. Their activation induces cell cycle arrest by inhibiting cyclin D–Cdk4/6 and cyclin E–Cdk2 and prevents Rb inactivation, resulting in continuous repression of E2F target genes required for S-phase. ARF can inhibit MDM2 and stabilize p53, which leads to the arrest of the cell cycle and cellular aging and the possibility of repairing minor damages. Accordingly, senescence is associated with several molecular and phenotypic alterations, such as senescence-associated secretory phenotype (SASP), cell cycle arrest, DNA damage response (DDR), senescence-associated β-galactosidase, morphogenesis, and chromatin remodeling. The anti-senesce effects of RJ and its component (MRJPs, 10-had, and RJPs) is the result of the interplay between several genes involved in downregulation of insulin/insulin-like growth factor-1 signaling (IIS) and targeting of rapamycin (mTOR), upregulation of the epidermal growth factor (EGF) signaling, dietary restriction, and enhancement of antioxidative capacity via Nrf2 activation. These signaling pathways affect cellular processes associated with longevity: DNA repair, autophagy, antioxidant activity, anti-inflammatory activity, stress resistance, and cell proliferation. In addition, RJ suppresses cellular senescence by upregulation of SOD1 and downregulation of Mtor and catenin beta like-1, and by regulating the expression levels of p53, p16, and p21. The life-expanding effect of RJ possibly originates from its antioxidant and anti-inflammatory properties, which can promote healthy aging by improving glycemic status, lipid profiles, and oxidative stress and hence can prevent the occurrence of various debilitating metabolic diseases. Furthermore, it should be noted that RJ contains epigenetically active compounds that inhibit DNMT3 or HDAC3, thus changing the epigenetic information generated in response to exogenous and endogenous factors during the aging process. Note: ATM, Ataxia telangiectasia mutated; ATR, Ataxia telangiectasia mutated and Rad3 related; BDNF, brain-derived neurotrophic factor; CDK2, Cyclin-dependent kinase 2; CDK4/6, Cyclin-dependent kinase 4 and 6; ER stress, Endoplasmic reticulum stress; NGF, nerve growth factor; Nrf2, nuclear factor-erythroid 2-related factor 2; p21 and p16, cyclin dependent kinase (CDK) inhibitors; Rb, retinoblastoma protein; ROS, Reactive oxygen species; SA-β-gal, senescence-associated β-galactosidase; SAHF, Senescence-associated heterochromatin foci; SASP, Senescence-associated secretory phenotype; TAFs, telomere-associated foci
Publication
Royal Jelly: Biological Action and Health Benefits (2024) Nada Oršolić, et al. Int J Mol Sci. 2024 Jun;25(11). Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | ATM | ATM | ncbigene_symbol | ATM | 472 |
| Homo sapiens | Primates | ARF | ARF | ncbigene_synonym | CDKN2A | 1029 |
| Homo sapiens | Primates | P16 | P16 | ncbigene_synonym | H3P10 | 115482713 |
| Homo sapiens | Primates | ATR | ATR | ncbigene_symbol | ATR | 545 |
| Homo sapiens | Primates | ATR | ATR | ncbigene_synonym | ANTXR1 | 84168 |
| Homo sapiens | Primates | ATR | ATR | ncbigene_synonym | MMAB | 326625 |
| Homo sapiens | Primates | ATR | ATR | ncbigene_synonym | SERPINA2 | 390502 |
| Homo sapiens | Primates | p53 | P53 | ncbigene_synonym | TP53 | 7157 |
| Homo sapiens | Primates | p53 | P53 | famplex_relations | TP63 | 8626 |
| Homo sapiens | Primates | p53 | P53 | famplex_relations | TP73 | 7161 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | ANGPT1 | 284 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | ANGPT2 | 285 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | ANGPT4 | 51378 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | AREG | 374 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | BDNF | 627 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | CSF1 | 1435 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | EFNA1 | 1942 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | EFNA2 | 1943 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | EFNA3 | 1944 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | EFNA4 | 1945 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | EFNA5 | 1946 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | EGF | 1950 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | EREG | 2069 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FGF1 | 2246 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FGF10 | 2255 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FGF16 | 8823 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FGF17 | 8822 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FGF18 | 8817 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FGF19 | 9965 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FGF2 | 2247 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FGF20 | 26281 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FGF21 | 26291 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FGF22 | 27006 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FGF23 | 8074 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FGF3 | 2248 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FGF4 | 2249 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FGF5 | 2250 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FGF6 | 2251 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FGF7 | 2252 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FGF8 | 2253 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FGF9 | 2254 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | FLT3LG | 2323 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | HGF | 3082 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | IGF1 | 3479 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | IGF2 | 3481 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | INS | 3630 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | KITLG | 4254 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | NGF | 4803 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | NTF3 | 4908 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | NTF4 | 4909 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | PDGFA | 5154 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | PDGFB | 5155 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | PDGFC | 56034 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | PDGFD | 80310 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | PGF | 5228 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | TGFA | 7039 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | VEGFA | 7422 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | VEGFB | 7423 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | VEGFC | 7424 |
| Homo sapiens | Primates | growthfactors | GROWTHFACTOR | famplex_relations | VEGFD | 2277 |
| Homo sapiens | Primates | p21 | P21 | ncbigene_synonym | CDKN1A | 1026 |
| Homo sapiens | Primates | p21 | P21 | ncbigene_synonym | TCEAL1 | 9338 |
| Homo sapiens | Primates | p21 | P21 | ncbigene_synonym | NSG1 | 27065 |
| Homo sapiens | Primates | p21 | P21 | ncbigene_synonym | H3P16 | 644914 |
| Homo sapiens | Primates | CDK2 | CDK2 | ncbigene_symbol | CDK2 | 1017 |
| Homo sapiens | Primates | CDK4/6 | CDK4 | ncbigene_symbol | CDK4 | 1019 |
| Homo sapiens | Primates | CDK4/6 | CDK6 | ncbigene_symbol | CDK6 | 1021 |
| Homo sapiens | Primates | fat | FAT | ncbigene_synonym | CD36 | 948 |
| Homo sapiens | Primates | fat | FAT | ncbigene_synonym | FAT1 | 2195 |
| Homo sapiens | Primates | (SAH) | SAH | ncbigene_synonym | ACSM3 | 6296 |
| Homo sapiens | Primates | SASP | SASP | ncbigene_synonym | ASPRV1 | 151516 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| ROS | ROS | chebi:26523 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|